US Patent 7579473 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Exelixis

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Exelixis

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 330 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
330 News #PharmaBuzz

DEVELOPMENTS

173 Drugs in Development

173 Drugs in Development

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 5 FDA Orange Book

5 FDF Dossiers
5 FDA Orange Book

INSPECTIONS & REGISTRATIONS

2 FDA

2 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 2EXELIXIS

02 3EXELIXIS INC

filter Patent Number Reset all filters

5 All

01 57579473

filter API Patent Reset all filters

5 All

01 5Y

filter FDF Patent Reset all filters

5 All

01 5Y

filter Expiration Date Reset all filters

5 All

01 52026-08-14

01

EXELIXIS INC

CABOZANTINIB S-MALATE

BioProcess International

Not Confirmed

EXELIXIS INC

BioProcess International

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-14

CABOZANTINIB S-MALATE

US Patent Number : 7579473

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208692

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

EXELIXIS INC

CABOZANTINIB S-MALATE

BioProcess International US West

Not Confirmed

EXELIXIS INC

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-14

CABOZANTINIB S-MALATE

US Patent Number : 7579473

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208692

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

EXELIXIS INC

CABOZANTINIB S-MALATE

BioProcess International US West

Not Confirmed

EXELIXIS INC

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-14

CABOZANTINIB S-MALATE

US Patent Number : 7579473

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208692

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

EXELIXIS

CABOZANTINIB S-MALATE

BioProcess International US West

Not Confirmed

EXELIXIS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-14

CABOZANTINIB S-MALATE

US Patent Number : 7579473

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

EXELIXIS

CABOZANTINIB S-MALATE

BioProcess International US West

Not Confirmed

EXELIXIS

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-14

CABOZANTINIB S-MALATE

US Patent Number : 7579473

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203756

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-14

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.